Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Falling Comet
1969.7000 28.10 (1.45%)
NSE May 29, 2025 15:21 PM
Volume: 941.6K
 

logo
Lupin Ltd.
12 Nov 2024
1969.70
1.45%
KRChoksey
Lupin’s revenue was largely in-line with our estimates (+2.3%). EBITDA and Adj. PAT beat our estimates significantly due to lower-than-expected COGS and lower than expected other expenses.
We increase our FY2E6 EPS estimates to INR 79.7 (previously: 78.8) as we anticipate expanding respiratory portfolio in Europe, upcoming injectable launches include glucagon and dalbavancin, and GLP-1 launch in India in 2026E will drive growth.
Prabhudas Lilladhar released a report for Lupin Ltd. on 16 May, 2025.
More from Lupin Ltd.
Recommended